Welcome to drugdiscoveryanddevelopment.co.uk
Click to listen highlighted text!
Welcome to drugdiscoveryanddevelopment.co.uk
Subscribe to newsletter
Facebook
Linkedin
X
Youtube
Linkedin
Twitter
Youtube
Tue 22 September 2026
A Pharma Press Global company
Subscribe to DDD newsletter
Search
Drug Discovery and Development
Drug Discovery
Investigational New Drug application
Phase 1-2 trials
Phase 3 trials
Approvals
Finance
Conferences
Journal
Drug Discovery
Investigational New Drug application
Phase 1-2 trials
Phase 3 trials
Approvals
Novartis remibrutinib significantly reduces relapse rates and shows favourable safety profile in phase 3 RMS trials
9 September 2026
GSK to advance mRNA seasonal flu vaccine candidate to phase 3 following positive phase 2 data
9 September 2026
New phase 3b data on Eli Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults...
8 September 2026
Acoramidis demonstrates reversal of cardiac structural disease progression and functional decline and significantly increases days alive and free from hospitalisation in ATTR-CM
8 September 2026
Tezspire demonstrates positive phase 3 results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
8 September 2026
Products
CDMO
CRO
Home
Authors
Posts by Editor
Editor
162 POSTS
0 COMMENTS
https://drugdiscoveryanddevelopment.co.uk
Phase 3 trials
AbbVie announces positive topline results from the phase 3 trial showing Etentamig significantly improved response rate and progression-free survival in patients with relapsed/refractory multiple...
Editor
-
4 September 2026
0
InnovHeart announces first US Saturn transseptal TMVR system implant, reaching 15 patients globally
Editor
-
4 September 2026
0
Drug Delivery and Supply Chain
Cipla announces exclusive partnership with Qilu Pharmaceutical for the licensing and supply of biosimilar to Keytruda (Pembrolizumab) in the US
Editor
-
4 September 2026
0
Drug Discovery
ENA Respiratory awarded Biointelect Venturer funding to support new study in asthma patients of INNA-051 nasal spray designed to protect against symptomatic viral respiratory infections
Editor
-
4 September 2026
0
Conferences and events
NextGen Biomed 2027 conference: the next generation of biotherapeutics takes shape in London
Editor
-
2 September 2026
0
Conferences and events
Cell 2026 conference: the whole ecosystem assembles in London, UK
Editor
-
2 September 2026
0
Drug Delivery and Supply Chain
Lubrizol targets drug delivery challenges at CPHI Milan
Editor
-
2 September 2026
0
Phase 1-2 trials
African Bundibugyo ebolavirus vaccine candidate advanced to clinical trials
Editor
-
28 August 2026
0
Phase 1-2 trials
NRG Therapeutics presents data on lead clinical asset NRG5051 confirming novel disease-modifying approach to ALS
Editor
-
28 August 2026
0
Phase 3 trials
VarmX enrols first participant in global phase 3 trial evaluating VMX‑C001 in urgent surgery
Editor
-
28 August 2026
0
1
2
3
...
17
Page 2 of 17
TOP AUTHORS
Editor
162 POSTS
0 COMMENTS
https://drugdiscoveryanddevelopment.co.uk
Julian English
36 POSTS
0 COMMENTS
https://drugdiscoveryanddevelopment.co.uk
Most Read
Novartis remibrutinib significantly reduces relapse rates and shows favourable safety profile in phase 3 RMS trials
9 September 2026
GSK to advance mRNA seasonal flu vaccine candidate to phase 3 following positive phase 2 data
9 September 2026
New phase 3b data on Eli Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults...
8 September 2026
Acoramidis demonstrates reversal of cardiac structural disease progression and functional decline and significantly increases days alive and free from hospitalisation in ATTR-CM
8 September 2026
Click to listen highlighted text!